ASPA 抗体 (AA 77-313)
-
- 抗原 See all ASPA 抗体
- ASPA (Aspartoacylase (ASPA))
-
抗原表位
- AA 77-313
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This ASPA antibody is un-conjugated
-
应用范围
- Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- 特异性
- Human ASPA
- 纯化方法
- Immunoaffinity purified
- 免疫原
-
Human recombinant protein fragment corresponding to amino acids 77-313 of human ASPA (NP_000040) produced in E. coli.
Type of Immunogen: Recombinant protein - 克隆位点
- 1A11
- 亚型
- IgG2a
- Top Product
- Discover our top product ASPA Primary Antibody
-
anti-Aspartoacylase (ASPA) antibody
ASPA 适用: 人 WB, IF, IHC (p), ICC, IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Aspartoacylase (ASPA) (AA 1-313) antibodyASPA 适用: 人 WB, IP 宿主: 兔 Polyclonal unconjugated
anti-Aspartoacylase (ASPA) (AA 82-110), (N-Term) antibodyASPA 适用: 人 WB, IF, IHC (p), FACS 宿主: 兔 Polyclonal RB20918 unconjugated
anti-Aspartoacylase (ASPA) (AA 89-118), (N-Term) antibodyASPA 适用: 人 WB, IF, IHC (p), FACS, EIA 宿主: 兔 Polyclonal unconjugated
anti-Aspartoacylase (ASPA) antibodyASPA 适用: 人, 小鼠, 大鼠 WB, IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Aspartoacylase (ASPA) (AA 1-100) antibodyASPA 适用: 人 WB, ELISA, IF 宿主: 小鼠 Monoclonal 3C11 unconjugated
anti-Aspartoacylase (ASPA) (AA 1-313) antibodyASPA 适用: 人 WB, IF 宿主: 兔 Polyclonal unconjugated
anti-Aspartoacylase (ASPA) antibodyASPA 适用: 人 WB, IHC, FACS, IF/ICC 宿主: 兔 Polyclonal unconjugated
anti-Aspartoacylase (ASPA) antibodyASPA 适用: 人, 小鼠, 大鼠 IF 宿主: 兔 Polyclonal unconjugated
anti-Aspartoacylase (ASPA) (AA 1-313) antibodyASPA 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
-
- 应用备注
- Approved: IHC, IHC-P (1:150)
- 说明
-
Target Species of Antibody: Human
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- PBS, pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- Minimize freezing and thawing.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C. Avoid freeze-thaw cycles.
-
-
